Aclacinomycin A hydrochloride,cas:75443-99-1
Aclacinomycin A hydrochloride
Product description
Aclarubicin hydrochloride (ACL)(C42H54ClNO15,848.3) is an anthracycline antibiotic developed by the Japanese pharmaceutical company, Daiichi Sankyo. It is derived from the bacterium Streptomyces peucetius and is structurally related to doxorubicin.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Aclacinomycin A hydrochloride
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


